Cannabidiol

Common brands: Epidiolex, Onfi, Keppra Xr, Keppra, Sympazan

Top reporter: Jazz Pharmaceuticals, Inc.

Benzodiazepine [EPC]Anti-epileptic Agent [EPC]Mood Stabilizer [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]
22,747
Total Reports
13,003
Serious Reports
1,802
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.92%)

Patient Demographics

Male
5,796
Female
5,604

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Cannabidiol.

# Reaction Reports % of Total
1 SEIZURE 5,910
19.4%
2 OFF LABEL USE 2,306
7.6%
3 HOSPITALISATION 2,247
7.4%
4 PRODUCT USE IN UNAPPROVED INDICATION 1,797
5.9%
5 DIARRHOEA 1,714
5.6%
6 DRUG INEFFECTIVE 1,365
4.5%
7 DEATH 1,272
4.2%
8 SOMNOLENCE 1,268
4.2%
9 FATIGUE 1,189
3.9%
10 PRODUCT DOSE OMISSION ISSUE 1,142
3.7%
11 WEIGHT DECREASED 849
2.8%
12 WEIGHT INCREASED 814
2.7%
13 VOMITING 725
2.4%
14 DECREASED APPETITE 701
2.3%
15 NAUSEA 654
2.1%
16 PNEUMONIA 614
2.0%
17 CONDITION AGGRAVATED 607
2.0%
18 PRODUCT ADMINISTRATION INTERRUPTED 548
1.8%
19 DRUG INTERACTION 529
1.7%
20 INSOMNIA 499
1.6%
21 FALL 490
1.6%
22 AGGRESSION 391
1.3%
23 RASH 383
1.3%
24 PYREXIA 371
1.2%
25 GENERALISED TONIC-CLONIC SEIZURE 367
1.2%
26 DIZZINESS 361
1.2%
27 HEADACHE 360
1.2%
28 CONSTIPATION 336
1.1%
29 COVID-19 327
1.1%
30 PAIN 326
1.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.